Commerzbank Aktiengesellschaft Abb Vie Inc. Transaction History

Commerzbank Aktiengesellschaft

$3.03 Billion
Q2 2024

A detailed history of Commerzbank Aktiengesellschaft transactions in Abb Vie Inc. stock. As of the latest transaction made, Commerzbank Aktiengesellschaft holds 14,768 shares of ABBV stock, worth $2.87 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

14,768

Previous 10,317 43.14%

Holding current value

$2.87 Million

Previous $1.88 Million 34.81%

% of portfolio

0.08%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $688,970 - $804,562	4,451 Added 43.14%	14,768 $2.53 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $246,442 - $280,798	1,542 Added 17.57%	10,317 $1.88 Million
Q4 2023 Feb 01, 2024	BUY	$137.6 - $154.97 $832,204 - $937,258	6,048 Added 221.78%	8,775 $1.36 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $364,299 - $421,730	2,727 New	2,727 $406,000
Q3 2022 Jun 08, 2023	BUY	$134.21 - $153.93 $796,670 - $913,728	5,936 New	5,936 $797,000
Q2 2020 Jul 21, 2020	SELL	$73.37 - $98.18 $1.92 Million - $2.57 Million	-26,210 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $32.5 Million - $49.3 Million	-503,767 Reduced 95.05%	26,210 $2 Million
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $8.25 Million - $10.3 Million	-114,348 Reduced 17.75%	529,977 $46.9 Million
Q3 2019 Oct 17, 2019	BUY	$62.98 - $75.72 $9.4 Million - $11.3 Million	149,303 Added 30.16%	644,325 $48.8 Million
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $13.7 Million - $17.5 Million	208,049 Added 72.5%	495,022 $36 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $6.04 Million - $7.11 Million	78,313 Added 37.53%	286,973 $23.1 Million
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $2.31 Million - $2.85 Million	29,646 Added 16.56%	208,660 $19.2 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $6.2 Million - $6.9 Million	-69,762 Reduced 28.04%	179,014 $16.9 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $1.5 Million - $1.77 Million	16,664 Added 7.18%	248,776 $23 Million
Q1 2018 May 01, 2018	BUY	$92.01 - $123.21 $14.3 Million - $19.2 Million	155,475 Added 202.87%	232,112 $22 Million
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $3.69 Million - $4.05 Million	41,227 Added 116.43%	76,637 $7.41 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.19 Million - $1.52 Million	17,049 Added 92.85%	35,410 $3.15 Million
Q2 2017 Aug 09, 2017	BUY	N/A	18,361	18,361 $1.33 Million

Others Institutions Holding ABBV

# of Institutions

3,692

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $343B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.

Account

Commerzbank Aktiengesellschaft Abb Vie Inc. Transaction History